← Leaderboards
Sean M Amberg
Kineta, Inc.
$19,068,485
Attributed
$19,068,485
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.9M · FY2006–23$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$19,068,485 · 4
By mechanism
R01$12,956,120 · 2
R44$6,037,067 · 1
F32$75,298 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Variant”
- Richard A Gibbs · Baylor College Of Medicine$367,607,426
- Richard K. Wilson · Washington University$295,336,569
- Stacey Gabriel · Massachusetts Institute Of Technology$169,231,712
- David Heimbrook · Leidos Biomedical Research, Inc.$125,120,179
- Heidi L Rehm · Broad Institute, Inc.$96,250,516
- Margaret A Pericak-Vance · Doheny Eye Institute$83,999,609
Research focus
VariantSafetyToxicologyResistanceLassa VirusLassa FeverEvaluationTacaribe Complex VirusesPharmacologyPharmaceutical PreparationsIn VivoDrug KineticsDrug Resistant VirusDrug ResistanceArenavirusCaviaMonitorIn VitroInvestigational New Drug ApplicationGlycoproteinsAnimalsDoseAntiviral AgentsViral
Grant awards (15)
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever$1,063,683
R01 · FY2023 · AI · contact PI
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever$1,118,000
R01 · FY2022 · AI · contact PI
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever$1,134,275
R01 · FY2021 · AI · contact PI
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever$1,163,830
R01 · FY2020 · AI · contact PI
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever$1,370,459
R01 · FY2019 · AI · contact PI
Antiviral Drugs for Arenaviruses$1,296,933
R01 · FY2015 · AI · contact PI
Antiviral Drugs for Arenaviruses$1,228,837
R01 · FY2014 · AI · contact PI
Antiviral Drugs for Arenaviruses$1,364,947
R01 · FY2013 · AI · contact PI
Antiviral Drugs for Arenaviruses$1,435,943
R01 · FY2012 · AI · contact PI
Antiviral Drugs for Arenaviruses$1,779,213
R01 · FY2011 · AI · contact PI
Antiviral Drugs for Lassa Fever Virus$3,901,282
R44 · FY2008 · AI · contact PI
Antiviral Drugs for Lassa Fever Virus$1,160,831
R44 · FY2007 · AI · contact PI
Antiviral Drugs for Lassa Fever Virus$974,954
R44 · FY2006 · AI · contact PI
Functional and Structural Studies of Env-mediated Fusion$31,526
F32 · FY2003 · AI
Functional and Structural Studies of Env-mediated Fusion$43,772
F32 · FY2001 · AI